Immobilized human IL-4Rα at 0.5 μg/ml (50 μL/well) can bind to Dupilumab with a linear range of 1.221 ng/ml-5 μg/ml.
Product Details
Product Details
Product Specification
Host | Human |
Synonyms | Interleukin-4 receptor subunit alpha, IL-4 receptor subunit alpha, IL-4R subunit alpha, IL-4R-alpha, IL-4RA, CD124 |
Accession | P24394 |
Clone Number | S-SC022 |
Antibody Type | Recombinant mAb |
Isotype | IgG4,k |
Application | Blocking of IL-4Rα signaling Functional assays |
Purification | Protein A |
Concentration | 2 mg/ml |
Endotoxin | <1EU/mg |
Conjugation | Unconjugated |
Physical Appearance | Liquid |
Storage Buffer | PBS pH7.4, containing no preservative |
Stability & Storage | 12 months from date of receipt / reconstitution, 2 to 8 °C as supplied |
Dilution
application | dilution | species |
ELISA | 1.221-5000 ng/ml |
Background
Dupilumab is a monoclonal antibody blocking interleukin 4 and interleukin 13, used for allergic diseases such as eczema (atopic dermatitis), asthma and nasal polyps which result in chronic sinusitis. It is also used for the treatment of eosinophilic esophagitis and prurigo nodularis.
Picture
Picture
ELISA
